Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Devon Asset Management is an asset management and venture capital firm. Its healthcare-focused arm, Devon Park Bioventures, invests in therapeutics, medical devices, diagnostics, and drug discovery technologies. Devon Park Bioventures closed a $55M fund in 2007, has made 19 investments, and has had 6 portfolio exits. Devonshire Asset Management manages $98.90M in assets as of September 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Devont Asset Management.